Results 161 to 170 of about 4,011,812 (307)
Editorial - Volume 18, Issue 6
Dianne Conrad
doaj +1 more source
Corrigendum to "A decision support system for multi-target disease diagnosis: A bioinformatics approach" [Heliyon Volume 6, Issue 3, March 2020, Article e03657]. [PDF]
Ayo FE +4 more
europepmc +1 more source
Screening and epitope characterization of Nidogen‐2‐specific nanobodies
Camel immunization and phage display were employed to generate high‐affinity VHH nanobodies against Nidogen‐2. After library construction, biopanning, ELISA screening, sequencing, and recombinant expression, selected nanobodies were purified and characterized, leading to the preliminary exploration of a nanobody‐based sandwich ELISA for specific ...
Jianchuan Wen +9 more
wiley +1 more source
Corrigendum to 'There is no 'I' in team but there may be a PA' [Future Healthcare Journal volume 6 (October 2019) 177-180]. [PDF]
Watkins J, Straughton K, King N.
europepmc +1 more source
Corrigendum to 'How I treat medullary thyroid cancer': [ESMO Open Volume 6, Issue 3, June 2021, 100183]. [PDF]
Kiesewetter B +3 more
europepmc +1 more source
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel +8 more
wiley +1 more source
Various Authors
doaj +1 more source

